The Author Response:
In children who undergo dextranomer/hyaluronic acid (Dx/ HA) injection, it is clear that the change of bladder bowel dysfunction (BBD) affects the incidence of postoperative febrile urinary tract infection (UTI)s. However, evidence whether injection treatment itself improves BBD is still weak. The study reported by Läckgren et al. (1) was designed retrospectively. They investigated postoperative BBD in 54 patients 7-12 yr after Dx/ HA injection treatment. They used nonstandardized questionnaires by mail. In our opinion, a prospective, randomized trial is mandatory to demonstrate the relationship between Dx/HA injection and bladder dysfunction.
In our study, the number of febrile UTI episodes decreased after Dx/HA injection, which might have been affected by the improvement of BBD. Unfortunately, due to the retrospective nature of our study, we could not analyze the indexes of postoperative BBD in the persistent reflux population that demonstrated BBD.
